Charles N. York II, COO and CFO at Day One Biopharmaceuticals, Inc. (DAWN), sold 12,130 shares at $11.60 ($141K) on 2026-02-17, disclosed to the SEC on 2026-02-18.
Seasonal sale ($141k) by COO and CFO — this insider has traded DAWN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.60 | 6,065 | $70K | 50.0% |
| 2 | $11.60 | 6,065 | $70K | 50.0% |
| Total | $11.60 avg | 12,130 | $141K | 100% |
| Filing → |
| DAWN | SELL | 2025-05-19 | $27K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $105K | — | Filing → |
| DAWN | SELL | 2024-11-19 | $34K | — | Filing → |